Abstract

Mucormycosis occurs primarily in patients with severe underlying illness, especially leukemia, lymphoma, and uncontrolled diabetes mellitus. Cutaneous mucormycosis is somewhat less frequently associated with systemic illness than other forms of mucormycosis. The associated mortality is significantly less than that related to rhinocerebral form. More recent reports have shown that primary cutaneous mucormycosis has emerged as an important form of the disease. It develops where a break in the integrity of the skin has occurred as a result of surgery, bum, or other forms of trauma. We report a case of primary cutaneous mucormycosis in a healthy person without systemic illness, which was successfully treated with amphotericin B therapy for 2 weeks. 

Keywords

Amphotericin B Cutaneous mucormycosis

KJMM 1998 December;3(2):200-204(5). Epub 2016 February 24
Copyright © 1998 by Korean Journal of Medical Mycology

Language

Korean/English

Author

Si Yong Kim; Department of Dermatology, Chosun University Medical School, Kwangju, Korea
Young Jo Kim; Department of Dermatology, Chosun University Medical School, Kwangju, Korea
Byoung Soo Chung; Department of Dermatology, Chosun University Medical School, Kwangju, Korea

Corresponding

Si Yong Kim, Department of Dermatology, Chosun University Medical School, Kwangju, Korea.

Publication history

Acknowledgements

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Si Yong Kim

Department of Dermatology, Chosun University Medical School, Kwangju, Korea

Young Jo Kim

Department of Dermatology, Chosun University Medical School, Kwangju, Korea

Byoung Soo Chung

Department of Dermatology, Chosun University Medical School, Kwangju, Korea

Since epub date 2016 February 24